{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:12:14Z","timestamp":1791825134938,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ijrobp.2015.04.016","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T20:45:17Z","timestamp":1439498717000},"page":"16-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy"],"prefix":"10.1016","volume":"93","author":[{"given":"Jonathan","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Dinniwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brierley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.04.016_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2006-939841","article-title":"Epidemiology of primary and secondary liver cancers","volume":"23","author":"Ananthakrishnan","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/02656736.2013.821528","article-title":"Radiofrequency ablation for hepatocellular carcinoma","volume":"29","author":"Nishikawa","year":"2013","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib4","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","article-title":"Position paper from the World Health Organization","volume":"41","author":"The World Health Organization Quality of Life assessment (WHOQOL)","year":"1995","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0959-8049(02)00098-9","article-title":"Baseline quality of life predicts survival in patients with advanced colorectal cancer","volume":"38","author":"Maisey","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib9","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2007.12.9510","article-title":"Quality of life scores predict survival among patients with head and neck cancer","volume":"26","author":"Karvonen-Gutierrez","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ijrobp.2006.03.026","article-title":"Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy","volume":"66","author":"Hawkins","year":"2006","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/02841860600936369","article-title":"Individualized image guided iso-NTCP based liver cancer SBRT","volume":"45","author":"Dawson","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.ijrobp.2005.03.072","article-title":"Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control","volume":"62","author":"Dawson","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib16","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1200\/JCO.2002.07.093","article-title":"Measuring health-related quality of life in patients with hepatobiliary cancers: The functional assessment of cancer therapy-hepatobiliary questionnaire","volume":"20","author":"Heffernan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","article-title":"Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement","volume":"50","author":"Groenvold","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib18","series-title":"EORTC QLQ-C30 Scoring Manual","author":"Fayers","year":"2001"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00520-010-1016-5","article-title":"Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials","volume":"19","author":"Maringwa","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1015276414526","article-title":"Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening","volume":"11","author":"Cella","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib22","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1200\/JCO.2013.49.9202","article-title":"Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases","volume":"31","author":"Soliman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cncr.22799","article-title":"Interpreting clinically significant changes in patient-reported outcomes","volume":"110","author":"Ringash","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/annonc\/mdj072","article-title":"Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma","volume":"17","author":"Steel","year":"2006","journal-title":"Ann Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.ijrobp.2015.04.016_bib25","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1111\/j.1524-4733.2007.00278.x","article-title":"Evaluating health-related quality of life in cancer clinical trials: The National Cancer Institute of Canada Clinical Trials Group experience","volume":"10","author":"Osoba","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib26","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2006.10.025","article-title":"Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases","volume":"67","author":"Katz","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejca.2010.01.008","article-title":"Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients","volume":"46","author":"Stintzing","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.6004\/jnccn.2009.0027","article-title":"NCCN clinical practice guidelines in oncology: Hepatobiliary cancers","volume":"7","author":"Benson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cncr.28382","article-title":"A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites","volume":"120","author":"Quinten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7525-7-102","article-title":"Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008","volume":"7","author":"Montazeri","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib34","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ijrobp.2007.08.058","article-title":"Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors","volume":"70","author":"Mendez Romero","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2011.05.022","article-title":"Treatment of primary liver cancer using highly-conformal radiotherapy with kV-image guidance and respiratory control","volume":"102","author":"Law","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib36","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/cncr.22297","article-title":"Assessment of symptom experience in patients undergoing hepatic resection or ablation","volume":"107","author":"Eid","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib37","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/bjs.9620","article-title":"Patient-reported outcomes in long-term survivors of metastatic colorectal cancer needing liver resection","volume":"101","author":"Rees","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archsurg.136.6.693","article-title":"A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma","volume":"136","author":"Poon","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib39","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1188\/08.ONF.E45-E52","article-title":"Symptom concerns and quality of life in hepatobiliary cancers","volume":"35","author":"Sun","year":"2008","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib40","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.suronc.2011.10.005","article-title":"Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment","volume":"21","author":"Toro","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib41","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/pon.725","article-title":"Quality of life in patients diagnosed with primary hepatocellular carcinoma: Hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere)","volume":"13","author":"Steel","year":"2004","journal-title":"Psychooncology"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11136-006-9133-9","article-title":"Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison with transcatheter arterial chemoembolization alone","volume":"16","author":"Wang","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"Cardenes","year":"2010","journal-title":"Clin Translat Oncol"},{"key":"10.1016\/j.ijrobp.2015.04.016_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","article-title":"Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma","volume":"111","author":"Culleton","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615004162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615004162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T06:20:59Z","timestamp":1567059659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615004162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0360301615004162"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.016","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}